AARP Virginia has unveiled its 2026 legislative agenda and at the top of the list is making medicine more affordable for ...

BMS looks forward to pivotal readouts for six assets in 2026, ensuring profits after patent expiries for Opdivo and Eliquis.

While I believe Pfizer will rebound eventually, it will take some time to do so, and it may not occur in 2026. In the ...

Bristol Myers Squibb (BMS) has agreed as part of a deal with the US government to provide Eliquis (apixaban) free of charge ...